Codexis Completes Transfer of CodeEvolver® Technology to Merck
Oct 05, 2016 11:00 am UTC| Business
REDWOOD CITY, Calif., Oct. 05, 2016 -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announced the completion of the second and final phase in the transfer of its proprietary CodeEvolver® protein...
Natus Medical to Hold 2016 Third Quarter Financial Results Conference Call on October 19th
Oct 05, 2016 11:00 am UTC| Business
PLEASANTON, Calif., Oct. 05, 2016 -- Natus Medical Incorporated (NASDAQ:BABY) today announced that the Company will release its 2016 third quarter financial results before the market opens on Wednesday, October 19th....
More Pediatricians Use and Recommend Exergen TemporalScanners Over Braun Ear Thermometers
Oct 05, 2016 11:00 am UTC| Business
WATERTOWN, Mass., Oct. 05, 2016 -- A new study among pediatricians shows that they use and recommend the Exergen TemporalScanner over Braun Thermoscan ear thermometers or any other thermometer brand. A full 42 percent...
ZIOPHARM to Present at the Jefferies Gene Editing/Therapy Summit
Oct 05, 2016 11:00 am UTC| Business
BOSTON, Oct. 05, 2016 -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer, will present at the Jefferies Gene Editing/Therapy Summit on Tuesday, October...
YRC Freight Driver Achieves 5 Million Accident-Free Miles
Oct 05, 2016 10:58 am UTC| Business
MEMPHIS, Tenn., Oct. 05, 2016 -- In his nearly 40-year career with YRC Freight, Joe Brown has driven five million miles – and hasn’t had one accident. The company will recognize his safety record with an event at 2 p.m....
Oct 05, 2016 10:56 am UTC| Business
HONG KONG, Oct. 05, 2016 -- The multinational consortium consisting of the companies Melco International Development Limited (“Melco”) (HKEx Code:200), Seminole HR Holdings LLC (“Hard Rock”) and Cyprus Phasouri (Zakaki)...
Insmed Announces Worldwide License Agreement with AstraZeneca for Oral DPP1 Inhibitor
Oct 05, 2016 10:55 am UTC| Business
BRIDGEWATER, N.J., Oct. 05, 2016 -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced a licensing agreement with AstraZeneca...